Stacked
Immune & GutResearch profile

KPV

Lysine-Proline-Valine · α-MSH (11-13) · Lys-Pro-Val

Think of it as a calming balm for your immune system.

KPV is like a friendly mediator for your body’s immune responses. It steps in to ease inflammation, especially in the gut, by calming down the overactive parts of your immune system that can cause trouble. Imagine it as a soothing presence that tells your body's defense team to take a breather, reducing unnecessary inflammation.

Research in mice has shown that KPV can help reduce gut inflammation, which might be interesting for those who struggle with digestive discomfort. It even seems to have some antimicrobial powers, acting directly against certain bacteria and fungi like a microscopic cleaning crew.

KPV also shows promise in calming allergic reactions. Think of it as a gentle whisper to your immune system to chill out a bit when it’s overreacting, which could mean fewer flare-ups for those with sensitive skin or allergies.

Who it's for

  • People who often experience gut discomfort and are looking for new options to explore.
  • Those dealing with skin allergies or sensitivities seeking a soothing solution.
  • Biohackers interested in cutting-edge immune system support.

Probably not for you if…

  • Anyone expecting a quick fix for severe autoimmune conditions.
  • People who prefer traditional medicine approaches and are wary of new peptides.

Editorial summary for research context · Not medical advice

Mechanism of Action

KPV is a tripeptide (Lys-Pro-Val) corresponding to the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH). Preclinical research suggests it exerts anti-inflammatory activity in part independent of melanocortin receptors, with proposed intracellular targets that downregulate NF-κB signaling, reduce pro-inflammatory cytokine release (TNF-α, IL-1β, IL-6), and attenuate neutrophil migration. Rodent models of experimental colitis have shown reduced mucosal inflammation and faster epithelial recovery. Oral, nasal, and subcutaneous routes have all appeared in the research literature.

Researched Benefits

Gut inflammation research

Murine DSS- and TNBS-induced colitis models demonstrated reduced disease activity scores, lower myeloperoxidase activity, and improved histological scores versus controls.

  • [Kannengiesser et al. 2008]
  • [Dalmasso et al. 2008]

Mast-cell and allergic inflammation modulation

Preclinical work indicates suppression of mast-cell degranulation and reduced allergic skin inflammation in rodent atopic-dermatitis models.

  • [Brzoska et al. 2008]

Antimicrobial activity

In-vitro studies suggest direct activity against Candida albicans and Staphylococcus aureus independent of host immune response.

  • [Cutuli et al. 2000]

Research Protocols

The following dosing ranges have appeared in published research protocols. Presented for informational purposes only — not a recommendation for human use.

Gut-focused research (oral)

Dosage
500 mcg
Frequency
twice daily
Timing
before meals
Cycle
6 weeks

Research protocols have used enteric-coated or compounded oral preparations dosed before meals for GI-targeted work.

Systemic inflammation research (subcutaneous)

Dosage
500 mcg
Frequency
once daily
Timing
morning
Cycle
4 weeks

Subcutaneous dosing has been used in skin- and systemic-inflammation models. Often combined with BPC-157 in gut-focused research stacks.

Reported Side Effects

  • Generally well tolerated in preclinical work with no major adverse events reported
  • Rare mild injection-site irritation reported anecdotally
  • Transient flushing with higher subcutaneous doses
  • Long-term human safety data is lacking

Contraindications

  • Pregnancy and lactation (no safety data)
  • Active melanoma (theoretical concern given structural relationship to α-MSH, although KPV lacks melanocortin receptor agonism at typical doses)
  • Known hypersensitivity to the peptide

Stacking Partners

Peptides commonly paired with KPV in published research and protocol write-ups.

Vendor Pricing

Stacked earns a commission on purchases via these links. It does not influence our Trust Scores.

Gear + Companions

Reconstitution supplies and research-backed supplement companions for KPV. Editorial picks only — we earn a commission through Amazon on the click, no sponsorship.

Gear you'll need

· Reconstitution + storage essentials
  • Bacteriostatic Water 30mL (0.9% Benzyl Alcohol)

    Empower Pharmacy / generic medical supply

    Reconstitutes every lyophilized peptide. 28-day viability refrigerated.

  • Insulin Syringes 31G × 5/16" × 0.5mL (100 count)

    EasyTouch

    31G × 0.5mL insulin syringes — the default size for sub-0.25mL peptide doses.

  • Alcohol Prep Pads (Sterile, 200 count)

    Dynarex

    Sterile 70% IPA prep pads — one per vial stopper + one per injection site.

  • 1-Quart Sharps Disposal Container

    BD / Becton Dickinson

    FDA-cleared sharps container — pharmacies won't accept improvised disposal.

Stacks well with

· Supplement companions — independent evidence, not sponsored
  • Omega-3 Fish Oil (Molecularly Distilled, 240 softgels)

    Nordic Naturals

    Omega-3s lower systemic inflammation across the same pathways healing-axis peptides act on. The combination is additive in pre-clinical work.

  • Collagen Peptides Unflavored (2 lb)

    Vital Proteins

    Connective-tissue repair needs substrate — healing peptides signal repair; collagen peptides provide the raw amino acids.

  • Magnesium Glycinate 400mg (240 capsules)

    Nested Naturals

    Most people are sub-optimal in magnesium — glycinate form pairs well with recovery-focused protocols + doesn't cause GI distress.

As an Amazon Associate we earn from qualifying purchases · Disclosed per FTC guidelines

Top Videos

Curated from YouTube — refreshed weekly. Stacked doesn't host or endorse external content.

Research Papers

  • The tripeptide KPV reduces IL-1β-induced inflammation in intestinal epithelial cells

    Dalmasso G, et al. · Inflammatory Bowel Diseases · 2008

    PubMed 18275077
  • Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo

    Brzoska T, et al. · Endocrine Reviews · 2008

    PubMed 18477713